Mabion S.A. (WSE:MAB)

Poland flag Poland · Delayed Price · Currency is PLN
7.39
-0.17 (-2.25%)
At close: Dec 12, 2025
-27.83%
Market Cap119.44M
Revenue (ttm)14.81M
Net Income (ttm)-59.30M
Shares Out16.16M
EPS (ttm)-3.68
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume48,618
Average Volume41,541
Open7.65
Previous Close7.56
Day's Range7.28 - 7.65
52-Week Range6.95 - 11.80
Beta0.40
RSI43.51
Earnings DateNov 25, 2025

About Mabion

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services. In addition, it offers cell line development, process development, production of a product for preclinical and clinical trials, development and validation of analytical methods, and preparation o... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 213
Stock Exchange Warsaw Stock Exchange
Ticker Symbol MAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.